Abstract
The genus Flavivirus contains approximately 70 viruses, and the major flaviviruses that cause human diseases are yellow fever virus (YFV), dengue virus (DV), West Nile virus (WNV), Japanese encephalitis virus (JEV), and tick-borne encephalitis virus [1]. The flaviviral particles contain single-stranded, positive-sensed RNA genome packaged within an icosahedral capsid formed by the capsid protein. The genome-containing capsid is surrounded by a host-derived lipid bilayer bearing dimers of the viral envelope protein and the membrane protein. The sizes of flavivirus virions are approximately 37–50 nm. Thus, the antigenic, genetic, and three-dimensional structures of all the flaviviruses are similar to each other.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Barrett A, Weaver S (2002) Arboviruses: alphaviruses flaviviruses and bunyaviruses. Med Microbiol 482–494
Murray P, Rosenthal K, Pfaller M (2005) Togaviruses and flaviviruses. Med Microbiol 619–628
Heinz FX, Allison SL (2003) Flavivirus structure and membrane fusion. Adv Virus Res 59:63–97
Johnson AJ, Guirakhoo F, Roehrig JT (1994) The envelope glycoproteins of dengue 1 and dengue 2 viruses grown in mosquito cells differ in their utilization of potential glycosylation sites. Virology 203:241–249
Mondotte JA, Lozach PY, Amara A, Gamarnik AV (2007) Essential role of dengue virus envelope protein N glycosylation at asparagine-67 during viral propagation. J Virol 81:7136–7148
Pokidysheva E, Zhang Y, Battisti AJ et al (2006) Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN. Cell 124:485–493
Modis Y, Ogata S, Clements D, Harrison SC (2003) A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci USA 100:6986–6991
Hanna SL, Pierson TC, Sanchez MD, Ahmed AA, Murtadha MM, Doms RW (2005) N-linked glycosylation of west nile virus envelope proteins influences particle assembly and infectivity. J Virol 79:13262–13274
Kawano H, Rostapshov V, Rosen L, Lai CJ (1993) Genetic determinants of dengue type 4 virus neurovirulence for mice. J Virol 67:6567–6575
Shirato K, Miyoshi H, Kariwa H, Takashima I (2006) The kinetics of proinflammatory cytokines in murine peritoneal macrophages infected with envelope protein-glycosylated or non-glycosylated West Nile virus. Virus Res 121:11–16
Davis CW, Nguyen HY, Hanna SL, Sanchez MD, Doms RW, Pierson TC (2006) West Nile virus discriminates between DC-SIGN and DC-SIGNR for cellular attachment and infection. J Virol 80:1290–1301
Wu SJ, Grouard-Vogel G, Sun W et al (2000) Human skin Langerhans cells are targets of dengue virus infection. Nat Med 6:816–820
Chen YC, Wang SY (2002) Activation of terminally differentiated human monocytes/macrophages by dengue virus: productive infection, hierarchical production of innate cytokines and chemokines, and the synergistic effect of lipopolysaccharide. J Virol 76:9877–9887
Navarro-Sanchez E, Altmeyer R, Amara A et al (2003) Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO Rep 4:723–728
Tassaneetrithep B, Burgess TH, Granelli-Piperno A et al (2003) DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J Exp Med 197:823–829
Miller JL, deWet BJ, Martinez-Pomares L et al (2008) The mannose receptor mediates dengue virus infection of macrophages. PLoS Pathog 4:e17
Chen ST, Lin YL, Huang MT et al (2008) CLEC5A is critical for dengue-virus-induced lethal disease. Nature 453:672–676
Bakker AB, Baker E, Sutherland GR, Phillips JH, Lanier LL (1999) Myeloid DAP12-associating lectin (MDL)-1 is a cell surface receptor involved in the activation of myeloid cells. Proc Natl Acad Sci USA 96:9792–9796
Brown GD, Taylor PR, Reid DM et al (2002) Dectin-1 is a major beta-glucan receptor on macrophages. J Exp Med 196:407–412
Brown GD, Gordon S (2001) Immune recognition. A new receptor for beta-glucans. Nature 413:36–37
Pang T, Cardosa MJ, Guzman MG (2007) Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS). Immunol Cell Biol 85:43–45
Theofilopoulos AN, Baccala R, Beutler B, Kono DH (2005) Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol 23:307–336
Rothlin CV, Ghosh S, Zuniga EI, Oldstone MB, Lemke G (2007) TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 131:1124–1136
Kong KF, Delroux K, Wang X et al (2008) Dysregulation of TLR3 impairs the innate immune response to West Nile virus in the elderly. J Virol 82:7613–7623
Sakuntabhai A, Turbpaiboon C, Casademont I et al (2005) A variant in the CD209 promoter is associated with severity of dengue disease. Nat Genet 37:507–513
Acknowledgments
This work is supported mainly by the National Research Program for Genomic Medicine, National Science Council, Taiwan (NSC-95-3112-B-010-0171 & NSC 96-3112-B-010-2), and in part by the National Yang-Ming University, Taiwan (96A-D-D132 from MOE), the Taipei Veterans General Hospital (V97S5-001), and Academia Sinica.
We are grateful to the resources and collaborative efforts provided by the RNAi Consortium, Academia Sinica, Taiwan, and the Consortium for Functional Glycomics, funded by NIGMS-GM62116 USA.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this paper
Cite this paper
Chen, ST., Lin, YL., Huang, MT., Wu, MF., Hsieh, SL. (2011). Targeting C-Type Lectin for the Treatment of Flavivirus Infections. In: Wu, A. (eds) The Molecular Immunology of Complex Carbohydrates-3. Advances in Experimental Medicine and Biology, vol 705. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-7877-6_40
Download citation
DOI: https://doi.org/10.1007/978-1-4419-7877-6_40
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-7876-9
Online ISBN: 978-1-4419-7877-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)